Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02224391 · ClinicalTrials.gov registry record · NA
Smartphone-Delivered Attentional Bias Modification Training in Helping Patients Quit Smoking
A NA study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 311
- Enrollment target
NCT02224391: Completed NA study, sponsored by M.D. Anderson Cancer Center.
NCT02224391 is a NA study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 311 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02224391, a NA study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 311 participants
- Enrollment target
Study Summary
This randomized clinical trial studies how well a smartphone-delivered attentional bias modification training works in helping patients quit smoking. Smartphone-delivered attentional bias modification training may help patients quit smoking by reducing the attentional bias (the tendency of one's perception to be affected by their recurring thoughts) towards smoking cues that developed over time as a result of conditioning processes through which smoking cues become important.
Interventions
- OTHER Laboratory Biomarker Analysis
- OTHER Questionnaire Administration
- DRUG Nicotine Patch
- OTHER Sham Intervention
- BEHAVIORAL Computer-Assisted Smoking Cessation Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 311 participants |
| Start Date | 2016-01-20 |
| Est. Completion | 2021-03-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02224391
The ClinicalTrials.gov registry entry for NCT02224391 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 311 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Laboratory Biomarker Analysis is the first listed.
NCT02224391 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02224391 about?
NCT02224391 is a clinical study titled "Smartphone-Delivered Attentional Bias Modification Training in Helping Patients Quit Smoking". This randomized clinical trial studies how well a smartphone-delivered attentional bias modification training works in helping patients quit smoking. Smartphone-delivered attentional bias modification training may help patients quit smoking by reducing the attentional bias (the tendency of one's per...
What is the current status of trial NCT02224391?
This trial is currently completed. It is a NA study. The enrollment target is 311 participants. The study started on 2016-01-20. Estimated completion is 2021-03-15.
What interventions are being tested in trial NCT02224391?
The interventions under investigation include: Laboratory Biomarker Analysis (OTHER), Questionnaire Administration (OTHER), Nicotine Patch (DRUG), Sham Intervention (OTHER), Computer-Assisted Smoking Cessation Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT02224391?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.